NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Aethlon Medical, Inc. (AEMD) Stock Analysis

Aethlon Medical, Inc. (AEMD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

AEMD

$1.82

−$0.11 (−5.70%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AEMD with… →

AEMD Key Statistics

As of Sep 4, 2026
Trading
Open
$1.79
Previous Close
$1.93
Day's Range
1.70–1.82
52-Week Range
1.67–41.50
Volume
162.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.40
Valuation
Market Cap
$1.29M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−14.65
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$7.15M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
711.14K
1-Year Return
−75.07%
Dividend and dates
Earnings Date
November 11, 2026
Avg Volume
1.07M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AEMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−34.30%
2025−95.97%
2024−60.73%
2023−21.79%
2022−84.95%
2021−24.70%
2020+157.29%
2019−96.14%
2018+46.90%
2017−73.10%
2016 (partial year)−34.88%

As of September 4, 2026.

AEMD Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$7.15M—
2024$0.00−$13.39M—
2023$0.00−$12.21M—
2022$574.25K−$12.03M−2094.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$7.29M−$7.15M—
2024$0.00—−$9.34M−$13.39M—
2023$0.00—−$12.64M−$12.21M—
2022$574.25K—−$11.90M−$12.03M−2094.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

AEMD Valuation vs Medical Devices Median

Median of 151 stocks
MetricAEMDMedical Devices medianvs median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Aethlon Medical, Inc. (AEMD) is capitalised at $1.29M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 9.

AEMD last closed at $1.82 on September 4, 2026. That is −$0.11 (−5.70%) against the previous close. Over the past 52 weeks the price has ranged from $1.67 to $41.50. The latest close sits 8.98% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $7.15M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −14.65.

Across the 4 fiscal years on file, revenue moves from $574.25K in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The trailing one-year price return is −75.07%. Measured over 10 years, that is −64.87% a year compounded. Beta against the wider market is reported at 1.4. Annualized volatility over the trailing 10 years is 223.1%.

Growth & Income

The record shows no dividend for AEMD.

Across the complete calendar years on file, 2020 returned +157.29% and 2019 returned −96.14%. Of the 9 complete calendar years on file, 2 finished higher. So far in 2026 the price is −34.30%.

Peer Comparison

Aethlon Medical, Inc. (AEMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Aethlon Medical, Inc. AEMD $1.29M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Aethlon Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Aethlon Medical, Inc.

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Visit website →